ARTICLE | Company News
GlaxoSmithKline, Medicines for Malaria Venture, University of California deal
October 15, 2001 7:00 AM UTC
The parties will develop malaria therapies. GSK will contribute certain patents covering the treatment and prevention of malaria by compounds that inhibit falcipain, a digestive enzyme used by the par...